CompanyDrug

Henlius Biotech Gets FDA Clearance for Clinical Study of PD-L1 Targeting ADC HLX43

CompanyDrug

CSPC Pharmaceutical Gets NMPA Green Light for SYH2038 Solid Tumor Study

CompanyDrug

Abbisko Therapeutics Launches Phase II Trial for Pimocitinib in Advanced Pancreatic Cancer

CompanyDeals

Xiamen Inno Medical Partners with Olympus to Advance AI in Digestive Endoscopy

CompanyMedical Device

Jenscare Reports Positive One-Year Outcomes for LuX-Valve in Tricuspid Valve Replacement Study

CompanyR&D

XtalPi Partners with University of Hong Kong’s ABIC to Advance Biomedical Technology Commercialization

CompanyDrug

Coherus Biosciences Sets Price for PD-1 Inhibitor Loqtorzi at $8,892.03, Offering 20% Discount Compared to Keytruda

Policy / Regulatory

China’s NHSA Issues Guidelines to Strengthen Medical Pricing and Procurement Credit Ratings

CompanyDeals

DxVx Secures License for OVM-200 Anti-Cancer Vaccine from Oxford Vacmedix

CompanyDeals

KingWise Partners with Truking Technology for Gynecological Tumor Gene Therapy Facilities

CompanyDrug

Takeda’s Takecab Receives NMPA Approval for Helicobacter pylori Eradication in China

CompanyDrug

Fujian Cosunter’s Oral COVID-19 Therapy Receives Conditional Approval in China